Skip to main content
Top
Published in: European Radiology 10/2010

01-10-2010 | Experimental

Percutaneous isolated liver perfusion with occlusion balloons and a catheter-based stent-graft-like perfusion device: an experimental study in a porcine model

Authors: Geert Maleux, Diethard Monbaliu, Chris Verslype, Christophe Casteleyn, Marc Van De Velde, Pieter Cornillie, Yvonne Hoogeveen, Eric Van Cutsem

Published in: European Radiology | Issue 10/2010

Login to get access

Abstract

Objective

To evaluate the feasibility and safety of a novel percutaneous isolated liver perfusion (PILP) system in a porcine model.

Methods

The PILP catheter set, consisting of a portal vein and hepatic artery occlusion balloon and an hourglass-shaped vena cava stent-graft, was tested in six Dutch Landrace pigs. A veno-venous bypass between the distal portal vein and the right femoral vein, and isolated perfusion between the proximal portal vein and the hepatic veins were also created. Leak rate was determined using radioactivity measurement in the systemic circulation. Perfusion was then performed without (n = 2) or with cytotoxic drugs (n = 4). At the end of the procedure, all devices were retrieved and angiographic evaluation was performed of the involved vessel segments.

Results

In all pigs it was possible to insert, accurately position and retrieve all components of the PILP catheter set without angiographic signs of vessel-wall damage. Leakage rates to the systemic circulation were less than 7% over the course of the perfusion.

Conclusion

In a porcine model, the PILP system can be safely and accurately positioned, and showed successful vascular isolation of the liver, with a leak rate to the systemic circulation of less than 7%.
Literature
1.
go back to reference Llovett JM, Real MI, Montana X, Planas R, Coll S, Aponte J, Ayuso C, Sala M, Muchart J, Solà R, Rodés J, Bruix J, Barcelona Liver Cancer Group (2002) Arterial embolization or chemoembolization versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet 359:1734–1739CrossRef Llovett JM, Real MI, Montana X, Planas R, Coll S, Aponte J, Ayuso C, Sala M, Muchart J, Solà R, Rodés J, Bruix J, Barcelona Liver Cancer Group (2002) Arterial embolization or chemoembolization versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet 359:1734–1739CrossRef
2.
go back to reference Sato KT, Lewandowski RJ, Mulcahy MF, Atassi B, Ryu RK, Gates VL, Nemcek AA Jr, Barakat O, Benson A 3rd, Mandal R, Talamonti M, Wong CY, Miller FH, Newman SB, Shaw JM, Thurston KG, Omary RA, Salem R (2008) Unresectable chemorefractory liver metastases: radioembolization with 90Y microspheres: safety, efficacy and survival. Radiology 247:507–515CrossRefPubMed Sato KT, Lewandowski RJ, Mulcahy MF, Atassi B, Ryu RK, Gates VL, Nemcek AA Jr, Barakat O, Benson A 3rd, Mandal R, Talamonti M, Wong CY, Miller FH, Newman SB, Shaw JM, Thurston KG, Omary RA, Salem R (2008) Unresectable chemorefractory liver metastases: radioembolization with 90Y microspheres: safety, efficacy and survival. Radiology 247:507–515CrossRefPubMed
3.
go back to reference Grover A, Alexander HR (2004) The past decade of experience with isolated hepatic perfusion. Oncologist 9:653–664CrossRefPubMed Grover A, Alexander HR (2004) The past decade of experience with isolated hepatic perfusion. Oncologist 9:653–664CrossRefPubMed
4.
go back to reference Rothbarth J, Tollenaar RA, van de Velde CJ (2006) Recent trends and future perspectives in isolated hepatic perfusion in the treatment of liver tumors. Expert Rev Anticancer Ther 6:553–565CrossRefPubMed Rothbarth J, Tollenaar RA, van de Velde CJ (2006) Recent trends and future perspectives in isolated hepatic perfusion in the treatment of liver tumors. Expert Rev Anticancer Ther 6:553–565CrossRefPubMed
5.
go back to reference Libutti SK, Bartlett DL, Fraker DL, Alexander HR (2000) Technique and results of hyperthermic isolated hepatic perfusion with tumor necrosis factor and melphalan for the treatment of unresectable hepatic malignancies. J Am Coll Surg 191:519–530CrossRefPubMed Libutti SK, Bartlett DL, Fraker DL, Alexander HR (2000) Technique and results of hyperthermic isolated hepatic perfusion with tumor necrosis factor and melphalan for the treatment of unresectable hepatic malignancies. J Am Coll Surg 191:519–530CrossRefPubMed
6.
go back to reference Alexander HR, Bartlett DL, Libutti SK, Pingpank JF, Fraker DL, Royal R, Steinberg SM, Helsabeck CB, Beresneva TH (2009) Analysis of factors associated with outcome in patients undergoing isolated hepatic perfusion for unresectable liver metastases from colorectal cancer. Ann Surg Oncol 16:1852–1859CrossRefPubMed Alexander HR, Bartlett DL, Libutti SK, Pingpank JF, Fraker DL, Royal R, Steinberg SM, Helsabeck CB, Beresneva TH (2009) Analysis of factors associated with outcome in patients undergoing isolated hepatic perfusion for unresectable liver metastases from colorectal cancer. Ann Surg Oncol 16:1852–1859CrossRefPubMed
7.
go back to reference Noter SL, Rothbarth J, Pijl ME, Keunen JE, Hartgrink HH, Tijl FG, Kuppen PJ, van de Velde CJ, Tollenaar RA (2004) Isolated hepatic perfusion with high-dose melphalan for the treatment of uveal melanoma metastases confined to the liver. Melanoma Res 14:67–72CrossRefPubMed Noter SL, Rothbarth J, Pijl ME, Keunen JE, Hartgrink HH, Tijl FG, Kuppen PJ, van de Velde CJ, Tollenaar RA (2004) Isolated hepatic perfusion with high-dose melphalan for the treatment of uveal melanoma metastases confined to the liver. Melanoma Res 14:67–72CrossRefPubMed
8.
go back to reference van Etten B, de Wilt JH, Brunstein F, Eggermont AM, Verhoef C (2009) Isolated hypoxic hepatic perfusion with melphalan in patients with irresectable ocular melanoma metastases. Eur J Surg Oncol 35:539–545PubMed van Etten B, de Wilt JH, Brunstein F, Eggermont AM, Verhoef C (2009) Isolated hypoxic hepatic perfusion with melphalan in patients with irresectable ocular melanoma metastases. Eur J Surg Oncol 35:539–545PubMed
9.
go back to reference van Iersel LB, Hoekman EJ, Gelderblom H, Vahrmeijer AL, van Persijn van Meerten EL, Tijl FG, Hartgrink HH, Kuppen PJ, Nortier JW, Tollenaar RA, van de Velde CJ (2008) Isolated hepatic perfusion with 200 mg melphalan for advanced noncolorectal liver metastases. Ann Surg Oncol 15:1891–1898CrossRefPubMed van Iersel LB, Hoekman EJ, Gelderblom H, Vahrmeijer AL, van Persijn van Meerten EL, Tijl FG, Hartgrink HH, Kuppen PJ, Nortier JW, Tollenaar RA, van de Velde CJ (2008) Isolated hepatic perfusion with 200 mg melphalan for advanced noncolorectal liver metastases. Ann Surg Oncol 15:1891–1898CrossRefPubMed
10.
go back to reference van Iersel LB, Gelderblom H, Vahrmeijer AL, van Persijn van Meerten EL, Tijl FG, Putter H, Hartgrink HH, Uppen PJ, Nortier JW, Tollenaar RA, van de Velde CJ (2008) Isolated hepatic melphalan perfusion of colorectal liver metastases: outcome and prognostic factors in 154 patients. Ann Oncol 19:1127–1134CrossRefPubMed van Iersel LB, Gelderblom H, Vahrmeijer AL, van Persijn van Meerten EL, Tijl FG, Putter H, Hartgrink HH, Uppen PJ, Nortier JW, Tollenaar RA, van de Velde CJ (2008) Isolated hepatic melphalan perfusion of colorectal liver metastases: outcome and prognostic factors in 154 patients. Ann Oncol 19:1127–1134CrossRefPubMed
11.
go back to reference van Iersel LB, Verlaan MR, Vahrmeijer AL, van Persijn van Meerten EL, Tijl FG, Sparidans RW, Gelderblom H, Kuppen PJ, Tollenaar RA, van de Velde CJ (2007) Hepatic artery infusion of high-dose melphalan at reduced flow during isolated hepatic perfusion for the treatment of colorectal metastases confined to the liver: A clinical and pharmacologic evaluation. Eur J Surg Oncol 33:874–881PubMed van Iersel LB, Verlaan MR, Vahrmeijer AL, van Persijn van Meerten EL, Tijl FG, Sparidans RW, Gelderblom H, Kuppen PJ, Tollenaar RA, van de Velde CJ (2007) Hepatic artery infusion of high-dose melphalan at reduced flow during isolated hepatic perfusion for the treatment of colorectal metastases confined to the liver: A clinical and pharmacologic evaluation. Eur J Surg Oncol 33:874–881PubMed
12.
go back to reference Alexander HR, Libutti SK, Pingpank JF, Bartlett DL, Helsabeck C, Beresneva T (2005) Isolated hepatic perfusion for the treatment of patients with colorectal cancer liver metastases after irinotecan-based therapy. Ann Surg Oncol 12:138–144CrossRefPubMed Alexander HR, Libutti SK, Pingpank JF, Bartlett DL, Helsabeck C, Beresneva T (2005) Isolated hepatic perfusion for the treatment of patients with colorectal cancer liver metastases after irinotecan-based therapy. Ann Surg Oncol 12:138–144CrossRefPubMed
13.
go back to reference Vahrmeijer AL, van Dierendonck JH, Keizer HJ, Beijnen JH, Tollenaar RA, Pijl ME, Marinelli A, Kuppen PJ, van Bockel JH, Mulder GJ, van de Velde CJ (2000) Increased local cytostatic drug exposure by isolated hepatic perfusion: a phase I clinical and pharmacologic evaluation of treatment with high dose melphalan in patients with colorectal cancer to the liver. Br J Cancer 82:1539–1546CrossRefPubMed Vahrmeijer AL, van Dierendonck JH, Keizer HJ, Beijnen JH, Tollenaar RA, Pijl ME, Marinelli A, Kuppen PJ, van Bockel JH, Mulder GJ, van de Velde CJ (2000) Increased local cytostatic drug exposure by isolated hepatic perfusion: a phase I clinical and pharmacologic evaluation of treatment with high dose melphalan in patients with colorectal cancer to the liver. Br J Cancer 82:1539–1546CrossRefPubMed
14.
go back to reference Rothbarth J, Pijl ME, Vahrmeijer AL, Hartgrink HH, Tijl FG, Kuppen PJ, Tollenaar RA, van de Velde CJ (2003) Isolated hepatic perfusion with high-dose melphalan for the treatment of colorectal metastasis confined to the liver. Br J Surg 90:1391–1397CrossRefPubMed Rothbarth J, Pijl ME, Vahrmeijer AL, Hartgrink HH, Tijl FG, Kuppen PJ, Tollenaar RA, van de Velde CJ (2003) Isolated hepatic perfusion with high-dose melphalan for the treatment of colorectal metastasis confined to the liver. Br J Surg 90:1391–1397CrossRefPubMed
15.
go back to reference Zeh HJ III, Brown CK, Holtzman MP, Egorin MJ, Holleran JL, Potter DM, Bartlett DL (2009) A phase I study of hyperthermic isolated hepatic perfusion with oxaliplatin in the treatment of unresectable liver metastases from colorectal cancer. Ann Surg Oncol 16:385–394CrossRefPubMed Zeh HJ III, Brown CK, Holtzman MP, Egorin MJ, Holleran JL, Potter DM, Bartlett DL (2009) A phase I study of hyperthermic isolated hepatic perfusion with oxaliplatin in the treatment of unresectable liver metastases from colorectal cancer. Ann Surg Oncol 16:385–394CrossRefPubMed
16.
go back to reference Pingpank JF, Libutti SK, Chang R, Wood BJ, Neeman Z, Kam AW, Figg WD, Zhai S, Beresneva T, Seidel GD, Alexander HR (2005) Phase I study of hepatic arterial melphalan infusion and hepatic venous hemofiltration using percutaneously placed catheters in patients with unresectable hepatic malignancies. J Clin Oncol 23:3465–3474CrossRefPubMed Pingpank JF, Libutti SK, Chang R, Wood BJ, Neeman Z, Kam AW, Figg WD, Zhai S, Beresneva T, Seidel GD, Alexander HR (2005) Phase I study of hepatic arterial melphalan infusion and hepatic venous hemofiltration using percutaneously placed catheters in patients with unresectable hepatic malignancies. J Clin Oncol 23:3465–3474CrossRefPubMed
17.
go back to reference van Etten B, Brunstein F, van Ijken MG, Marinelli AW, Verhoef C, van der Sijp JR, Guetens G, de Boeck G, de Bruijn EA, de Wilt JH, Eggermont AM (2004) Isolated hypoxic hepatic perfusion with orthograde or retrograde flow in patients with irresectable liver metastases using percutaneous balloon catheter techniques: a phase I–II study. Ann Surg Oncol 11:598–605CrossRefPubMed van Etten B, Brunstein F, van Ijken MG, Marinelli AW, Verhoef C, van der Sijp JR, Guetens G, de Boeck G, de Bruijn EA, de Wilt JH, Eggermont AM (2004) Isolated hypoxic hepatic perfusion with orthograde or retrograde flow in patients with irresectable liver metastases using percutaneous balloon catheter techniques: a phase I–II study. Ann Surg Oncol 11:598–605CrossRefPubMed
18.
go back to reference Savier E, Azoulay D, Huguet E, Lokiec F, Gil-Delgado M, Bismuth H (2003) Percutaneous isolated hepatic perfusion for chemotherapy: a phase 1 study. Arch Surg 138:325–332CrossRefPubMed Savier E, Azoulay D, Huguet E, Lokiec F, Gil-Delgado M, Bismuth H (2003) Percutaneous isolated hepatic perfusion for chemotherapy: a phase 1 study. Arch Surg 138:325–332CrossRefPubMed
19.
go back to reference Eggermont AM, van Ijken MG, van Etten B, van der Sijp JR, ten Hagen TL, Wiggers T, Oudkerk M, de Boeck G, de Bruijn EA (2000) Isolated hypoxic hepatic perfusion (IHHP) using balloon catheter techniques: from laboratory to the clinic towards a percutaneous procedure. Hepatogastroenterology 47:776–781PubMed Eggermont AM, van Ijken MG, van Etten B, van der Sijp JR, ten Hagen TL, Wiggers T, Oudkerk M, de Boeck G, de Bruijn EA (2000) Isolated hypoxic hepatic perfusion (IHHP) using balloon catheter techniques: from laboratory to the clinic towards a percutaneous procedure. Hepatogastroenterology 47:776–781PubMed
20.
go back to reference van Ijken MG, de Bruijn EA, de Boeck G, ten Hagen TL, van der Sijp JR, Eggermont AM (1998) Isolated hypoxic hepatic perfusion with tumor necrosis factor-alfa, melphalan, and mitomycine C using balloon catheter techniques: a pharmacokinetic study in pigs. Ann Surg 228:763–770CrossRefPubMed van Ijken MG, de Bruijn EA, de Boeck G, ten Hagen TL, van der Sijp JR, Eggermont AM (1998) Isolated hypoxic hepatic perfusion with tumor necrosis factor-alfa, melphalan, and mitomycine C using balloon catheter techniques: a pharmacokinetic study in pigs. Ann Surg 228:763–770CrossRefPubMed
21.
go back to reference Verhoef C, de Wilt JH, Brunstein F, Marinelli AW, van Etten B, Vermaas M, Guetens G, de Boeck G, de Bruijn EA, Eggermont AM (2008) Isolated hypoxic hepatic perfusion with retrograde outflow in patients with irresectable liver metastases: a new simplified technique in isolated hepatic perfusion. Ann Surg Oncol 15:1367–1374CrossRefPubMed Verhoef C, de Wilt JH, Brunstein F, Marinelli AW, van Etten B, Vermaas M, Guetens G, de Boeck G, de Bruijn EA, Eggermont AM (2008) Isolated hypoxic hepatic perfusion with retrograde outflow in patients with irresectable liver metastases: a new simplified technique in isolated hepatic perfusion. Ann Surg Oncol 15:1367–1374CrossRefPubMed
22.
go back to reference Harnek J, Cwikiel W, Bergqvist L, Persson B, Stridbeck H (1996) Isolated liver perfusion using percutaneous methods: an experimental study in the pig. Cardiovasc Intervent Radiol 19:418–422CrossRefPubMed Harnek J, Cwikiel W, Bergqvist L, Persson B, Stridbeck H (1996) Isolated liver perfusion using percutaneous methods: an experimental study in the pig. Cardiovasc Intervent Radiol 19:418–422CrossRefPubMed
23.
go back to reference Beheshti MV, Denny DF Jr, Glickman MG, Bodden W, March JC, Strair R, Ravikumar TS (1992) Percutaneous isolated liver perfusion for treatment of hepatic malignancy: preliminary report. J Vasc Intervent Radiol 3:453–458CrossRef Beheshti MV, Denny DF Jr, Glickman MG, Bodden W, March JC, Strair R, Ravikumar TS (1992) Percutaneous isolated liver perfusion for treatment of hepatic malignancy: preliminary report. J Vasc Intervent Radiol 3:453–458CrossRef
24.
go back to reference Rothbarth J, Pijl ME, Tollenaar RA, Tijl F, Ivancev K, Mulders GJ, Kuppen PJ, van de Velde CJ, Schultze Kool LJ (2003) An experimental minimally invasive perfusion technique for the treatment of liver metastases. Eur J Surg Oncol 29:757–763CrossRefPubMed Rothbarth J, Pijl ME, Tollenaar RA, Tijl F, Ivancev K, Mulders GJ, Kuppen PJ, van de Velde CJ, Schultze Kool LJ (2003) An experimental minimally invasive perfusion technique for the treatment of liver metastases. Eur J Surg Oncol 29:757–763CrossRefPubMed
25.
go back to reference Dondelinger RF, Ghysels MP, Brisbois D, Donkers E et al (1998) Relevant radiological anatomy of the pig as a training model in interventional radiology. Eur Radiol 8:1254–1273CrossRefPubMed Dondelinger RF, Ghysels MP, Brisbois D, Donkers E et al (1998) Relevant radiological anatomy of the pig as a training model in interventional radiology. Eur Radiol 8:1254–1273CrossRefPubMed
Metadata
Title
Percutaneous isolated liver perfusion with occlusion balloons and a catheter-based stent-graft-like perfusion device: an experimental study in a porcine model
Authors
Geert Maleux
Diethard Monbaliu
Chris Verslype
Christophe Casteleyn
Marc Van De Velde
Pieter Cornillie
Yvonne Hoogeveen
Eric Van Cutsem
Publication date
01-10-2010
Publisher
Springer-Verlag
Published in
European Radiology / Issue 10/2010
Print ISSN: 0938-7994
Electronic ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-010-1816-5

Other articles of this Issue 10/2010

European Radiology 10/2010 Go to the issue